iCo Therapeutics (CVE:ICO) and Devonian Health Group (CVE:GSD) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, valuation, risk, analyst recommendations, earnings, dividends and profitability.
Profitability
This table compares iCo Therapeutics and Devonian Health Group's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
iCo Therapeutics | N/A | N/A | N/A |
Devonian Health Group | N/A | N/A | N/A |
Analyst Recommendations
This is a breakdown of recent ratings and target prices for iCo Therapeutics and Devonian Health Group, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
iCo Therapeutics | 0 | 0 | 0 | 0 | N/A |
Devonian Health Group | 0 | 0 | 0 | 0 | N/A |
Valuation & Earnings
This table compares iCo Therapeutics and Devonian Health Group's top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
iCo Therapeutics | N/A | N/A | N/A | C($0.01) | -8.75 |
Devonian Health Group | C$1.59 million | 15.78 | C$-4,457,184.00 | C($0.05) | -5.63 |
iCo Therapeutics has higher earnings, but lower revenue than Devonian Health Group. iCo Therapeutics is trading at a lower price-to-earnings ratio than Devonian Health Group, indicating that it is currently the more affordable of the two stocks.
Summary
Devonian Health Group beats iCo Therapeutics on 2 of the 3 factors compared between the two stocks.